Outcomes of cesarean myomectomy in Singleton compared with twin pregnancies: a 10-year retrospective cohort study

单胎妊娠与双胎妊娠剖宫产子宫肌瘤切除术结局的比较:一项为期10年的回顾性队列研究

阅读:1

Abstract

BACKGROUND: To evaluate and compare the pregnancy outcomes after cesarean myomectomy in singleton and twin pregnancies. METHODS: We retrospectively reviewed 100 pregnant women diagnosed with myoma who underwent cesarean myomectomy at Chungnam National University Hospital between January 2012 and July 2022. Of them, 77 were singleton pregnancies and 23 were twin pregnancies. Maternal characteristics, largest myoma size, number of myomas, and surgical outcomes were compared between two groups. Myomas were further categorized based on their size; large myomas were defined as lesions measuring ≥ 5 cm in diameter. Maternal characteristics, preoperative and postoperative hemoglobin levels, operative time, and length of hospital stay were compared between the two subgroups. Continuous variables were compared using the Mann-Whitney U test, and categorical variables were assessed using the chi-square test. RESULTS: No significant differences were observed in the maternal characteristics, largest myoma size, number of myomas, or surgical outcomes between singleton and twin pregnancies. However, subgroup analysis based on the largest myoma size (≥ 5 vs. <5 cm) revealed significant differences in operative time (95.5 vs. 122.0 min, p < 0.001) and the need for transfusion (15.6% vs. 36.1%, p = 0.026). Otherwise, no significant differences were noted in the preoperative and postoperative hemoglobin levels or the need for massive transfusion (p > 0.999). No patient required interventions, such as the insertion of an intrauterine Foley balloon, uterine artery embolization, or hysterectomy. CONCLUSIONS: Cesarean myomectomy is safe and effective in both singleton and twin pregnancies, even in patients with large myomas.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。